Click to copy
Click to copy
Related topics

Zynerba: 2Q Earnings Snapshot

August 6, 2019

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Tuesday reported a loss of $11.1 million in its second quarter.

On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 50 cents.

The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 50 cents per share.

Zynerba shares have more than tripled since the beginning of the year. The stock has increased 75% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE

All contents © copyright 2019 The Associated Press. All rights reserved.